BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33399535)

  • 21. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection.
    Rowntree LC; Nguyen THO; Kedzierski L; Neeland MR; Petersen J; Crawford JC; Allen LF; Clemens EB; Chua B; McQuilten HA; Minervina AA; Pogorelyy MV; Chaurasia P; Tan HX; Wheatley AK; Jia X; Amanat F; Krammer F; Allen EK; Sonda S; Flanagan KL; Jumarang J; Pannaraj PS; Licciardi PV; Kent SJ; Bond KA; Williamson DA; Rossjohn J; Thomas PG; Tosif S; Crawford NW; van de Sandt CE; Kedzierska K
    Immunity; 2022 Jul; 55(7):1299-1315.e4. PubMed ID: 35750048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Single-Cell Atlas of Lymphocyte Adaptive Immune Repertoires and Transcriptomes Reveals Age-Related Differences in Convalescent COVID-19 Patients.
    Bieberich F; Vazquez-Lombardi R; Yermanos A; Ehling RA; Mason DM; Wagner B; Kapetanovic E; Di Roberto RB; Weber CR; Savic M; Rudolf F; Reddy ST
    Front Immunol; 2021; 12():701085. PubMed ID: 34322127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCR meta-clonotypes for biomarker discovery with
    Mayer-Blackwell K; Schattgen S; Cohen-Lavi L; Crawford JC; Souquette A; Gaevert JA; Hertz T; Thomas PG; Bradley P; Fiore-Gartland A
    Elife; 2021 Nov; 10():. PubMed ID: 34845983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones.
    Minervina AA; Pogorelyy MV; Komech EA; Karnaukhov VK; Bacher P; Rosati E; Franke A; Chudakov DM; Mamedov IZ; Lebedev YB; Mora T; Walczak AM
    Elife; 2020 Feb; 9():. PubMed ID: 32081129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative analysis of TCR immune repertoire in COVID-19 patients.
    Zhu X; Ma E; Ning K; Feng X; Quan W; Wang F; Zhu C; Ma Y; Dong Y; Jiang Q
    Hum Immunol; 2024 May; 85(3):110795. PubMed ID: 38582657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity.
    Yang G; Wang J; Sun P; Qin J; Yang X; Chen D; Zhang Y; Zhong N; Wang Z
    Front Immunol; 2023; 14():1146196. PubMed ID: 36969254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
    Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
    Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8
    Ford ES; Mayer-Blackwell K; Jing L; Sholukh AM; St Germain R; Bossard EL; Xie H; Pulliam TH; Jani S; Selke S; Burrow CJ; McClurkan CL; Wald A; Holbrook MR; Eaton B; Eudy E; Murphy M; Postnikova E; Robins HS; Elyanow R; Gittelman RM; Ecsedi M; Wilcox E; Chapuis AG; Fiore-Gartland A; Koelle DM
    Res Sq; 2022 Oct; ():. PubMed ID: 36263073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era.
    Buhler S; Sollet ZC; Bettens F; Schäfer A; Ansari M; Ferrari-Lacraz S; Villard J
    HLA; 2023 Dec; 102(6):720-730. PubMed ID: 37461808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of machine learning to identify a T cell response to SARS-CoV-2.
    Shoukat MS; Foers AD; Woodmansey S; Evans SC; Fowler A; Soilleux EJ
    Cell Rep Med; 2021 Feb; 2(2):100192. PubMed ID: 33495756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2-reactive T-cell receptors isolated from convalescent COVID-19 patients confer potent T-cell effector function.
    Brunk F; Moritz A; Nelde A; Bilich T; Casadei N; Fraschka SAK; Heitmann JS; Hörber S; Peter A; Rammensee HG; Singh H; Walz J; Maurer D; Wagner C
    Eur J Immunol; 2021 Nov; 51(11):2651-2664. PubMed ID: 34424997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8
    Minervina AA; Pogorelyy MV; Kirk AM; Crawford JC; Allen EK; Chou CH; Mettelman RC; Allison KJ; Lin CY; Brice DC; Zhu X; Vegesana K; Wu G; Trivedi S; Kottapalli P; Darnell D; McNeely S; Olsen SR; Schultz-Cherry S; Estepp JH; ; McGargill MA; Wolf J; Thomas PG
    Nat Immunol; 2022 May; 23(5):781-790. PubMed ID: 35383307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-reactivity of SARS-CoV-2- and influenza A-specific T cells in individuals exposed to SARS-CoV-2.
    Chaisawangwong W; Wang H; Kouo T; Salathe SF; Isser A; Bieler JG; Zhang ML; Livingston NK; Li S; Horowitz JJ; Samet RE; Zyskind I; Rosenberg AZ; Schneck JP
    JCI Insight; 2022 Sep; 7(18):. PubMed ID: 36134660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
    Lehmann AA; Kirchenbaum GA; Zhang T; Reche PA; Lehmann PV
    Front Immunol; 2021; 12():635942. PubMed ID: 34127926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of B Cell Receptor Repertoires Reveals Key Signatures of the Systemic B Cell Response after SARS-CoV-2 Infection.
    Zhang Y; Yan Q; Luo K; He P; Hou R; Zhao X; Wang Q; Yi H; Liang H; Deng Y; Hu F; Li F; Liu X; Feng Y; Li P; Qu L; Chen Z; Pan-Hammarström Q; Feng L; Niu X; Chen L
    J Virol; 2022 Feb; 96(4):e0160021. PubMed ID: 34878902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CD4
    Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
    Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Analysis of Human Memory T-Cell Response According to the Severity of Illness up to 8 Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Kang CK; Kim M; Lee S; Kim G; Choe PG; Park WB; Kim NJ; Lee CH; Kim IS; Jung K; Lee DS; Shin HM; Kim HR; Oh MD
    J Infect Dis; 2021 Jul; 224(1):39-48. PubMed ID: 33755725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.